CD8A and neoplasm: Other vaccine strategies such as DNA vaccines [30], [31], DC vaccines [32], tumor cell/extracts [33] showed the capacity to generate specific effecter CD8+ T cells, but there is no direct comparison of which vaccine has a higher ability to induce a CD8+ T cell response.